823-17-6

Basic information

• Product Name: 3,5-dimethylcyclohexene
• Synonyms: 3,5-dimethylcyclohexene
• CAS NO: 823-17-6
• Molecular Weight: 110.199
• Mol File: 823-17-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3,5-dimethylcyclohexene(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-dimethylcyclohexene(823-17-6)
• EPA Substance Registry System: 3,5-dimethylcyclohexene(823-17-6)

Safety Data

• Hazardous Substances Data: 823-17-6(Hazardous Substances Data)

Upstream product

• 5441-52-1 3,5-dimethylcyclohexan-1-ol 
• 83269-44-7 (3,5-dimethylcyclohex-2-enyl)trimethylgermane 
• 67-56-1 methanol 
• 76-05-1 trifluoroacetic acid 
• 1123-09-7 3,5-dimethyl-2-cyclohexen-1-one 
• 60-29-7 diethyl ether 
• 860748-70-5 3-chloro-1,5-dimethyl-cyclohexa-1,3-diene 
• 917-64-6 methyl magnesium iodide 
• 5435-44-9 (E)-3-Ureido-but-2-enoic acid ethyl ester 
• 41176-83-4 (+/-)-2c,4t-dimethyl-cyclohex-r-ylamine; hydrochloride 

Downstream Products

• 632-92-8 2,4-dimethyl-1,3,5-trinitrobenzene 
• 638-04-0 cis-1,3-dimethylcyclohexane 
• 2207-03-6 trans-1,3-dimethylcyclohexane 

Relevant articles and documents

Effect of ketene additive and Si/Al ratio on the reaction of methanol over HZSM-5 catalysts

The influence of ketene as possible intermediate for the reaction of methanol to aromatics was investigated over HZSM-5 catalysts (Si/Al ratio of 15 and 9) using diketene-acetone (2,2,6-trimethyl-4H-1,3-dioxin-4-one) as ketene precursor under atmospheric

Fused cycloalkyl amides and acids and their therapeutic applications

The present invention relates to the use of compounds of formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.

Electrophilic Substitution with Allylic Rearrangement (SE'). Anti Stereoselectivity in Trifluoroacetolysis of Some Cyclohex-2-enylsilanes, -germanes, and -stannanes

Trifluoroacetolysis of various cyclohex-2-enylsilanes, -germanes, and -stannanes is demonstrated to be γ regiospecific and highly anti stereoselective, as predicted for a dominating LUMO-HOMO interaction in a concerted SE2'process.